You have 9 free searches left this month | for more free features.

Condition

Advanced Malignancies (1)

NSCLC (1)

Ovarian Cancer (1)

Solid Tumors (1)

Urothelial Cancer (1)

Overall Status

Recruiting (1)

Sign in for free

Phase

phase 3 (1)

Sponsor

Pfizer (1)

Collaborator

Intervention

avelumab (1)

axitinib (1)

cmp 001 (1)

lorlatanib (1)

pemetrexed (1)

pf04518600 (1)

talazoparib (1)

utomilumab (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (1)

Study Type

Interventional (1)

lorlatanib

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Advanced Malignancies, NSCLC, Ovarian Cancer Trial in Worldwide (Avelumab, Lorlatanib, Talazoparib)

Recruiting

Advanced Malignancies
+4 more

Avelumab
+7 more

Fayetteville, Arkansas
+61 more

Jan 10, 2023